The nation of Zimbabwe has declined a major American healthcare agreement worth $367m (£272m) over five years because of Washington's demand for confidential information.
The decision became public after a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa believed the agreement was "unbalanced".
A government representative has since stated that the US was demanding access to biological samples for scientific study and commercial gain but was unwilling to share the benefits from any future treatments.
"We are forced to start the challenging and unfortunate process of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had donated over $1.9bn in health funding to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for further dialogue to reach a deal agreeable to both sides so the nation's critical HIV treatment initiative can be sustained.
Wider Context
This rejection comes after a comparable case in neighbouring Kenya, where a high court blocked a similar deal with the US following concerns were raised about the security of citizens' medical information.
After returning to office recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
The agency had administered assistance for the US government, but Trump argued its expenditure was "wasteful" and his administration was seeking direct bilateral deals to boost openness and accountability.
According to statements, 16 nations in Africa have so far signed these new health pacts, constituting more than $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment via US-supported initiatives," the Ambassador added.
However, official spokesman Nick Mangwana argued the arrangement was "unfair".
"Zimbabwe was being asked to provide its biological resources and data for a long time, without any equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Put simply, our country would provide the raw materials for medical research with no certainty that the final treatments would be available to our people should a new pandemic emerge."
National Interest and International Frameworks
He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining systems previously established through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing system designed to manage potential global health emergencies.
"This mechanism is intended to guarantee that when a country contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We welcome ongoing dialogue with our US partners on how future collaboration might be designed in a way that respects the independence and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but urged that negotiations must proceed given that a large portion of the country's HIV programmes relied on foreign aid.
"Where technical issues arise, such as those relating to data governance or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," it said.
The halted deal emphasises the continuing challenges between accepting vital international aid and safeguarding national sovereignty in an ever more interconnected world.